+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Addictions Therapeutics Market by Type and Geography - Forecast and Analysis 2019-2023 - Product Image

Addictions Therapeutics Market by Type and Geography - Forecast and Analysis 2019-2023

  • ID: 4845482
  • Report
  • September 2019
  • Region: Global
  • 155 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Alkermes Plc
  • Indivior Plc
  • Mylan NV
  • Novartis AG
  • Novo Nordisk AS
  • Pfizer Inc.
  • MORE
Global Addictions Therapeutics Market: About this market
The addictions therapeutics market analysis considers sales from alcohol addiction therapeutics, tobacco addiction therapeutics, and drug addiction therapeutics type. Our analysis also considers the sales of addictions therapeutics in Asia, Europe, North America, and ROW. In 2018, the alcohol addiction therapeutics segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the rise in alcohol addiction around the globe will play a significant role in the alcohol addiction therapeutics segment to maintain its market position. Also, our global addictions therapeutics market report looks at factors such as the high consumption of alcohol, tobacco, and opioid products, approval of new drugs and launch of digital therapeutics to treat addiction, and initiatives to increase awareness about and combat addiction. However, minimum insurance coverage for addiction treatment, stringent government policies and regulations, and social stigma among the drug-addicted population may hamper the growth of the addictions therapeutics industry over the forecast period.

Global Addictions Therapeutics Market: Overview

Initiatives to increase awareness about and combat addiction
There is an increase in the awareness about substance abuse and combat drug abuse due to the growing number of initiatives undertaken by federal departments and agencies. For instance, in India, drug abuse among the population is high, particularly in areas of Punjab, Haryana, and Uttar Pradesh. Therefore, the government of these states has undertaken special steps to combat drug abuse. They are providing information and resources to increase the understanding of addiction, drug and alcohol prevention, awareness about heroin/opioid epidemic, and more. Such initiatives will boost the demand for addiction therapeutics and lead to the expansion of the global addictions therapeutics market at a CAGR of over 5% during the forecast period.

Emergence of free state-run addiction treatment programs and facilities
Free treatment facilities and addiction treatment programs are available for those individuals struggling with substance use disorders who cannot otherwise afford the treatment. State-funded drug rehabilitation centers provide services such as free detox, inpatient facility stay, outpatient services, and other drug rehabilitation services. The availability of these treatment facilities is increasing the demand for addiction therapeutics. These free clinics and rehabilitation centers help people who are struggling with the physical, emotional, and financial costs of addiction. This is expected to have a positive impact on the overall market growth.

Competitive Landscape
With the presence of several major players, the global addictions therapeutics market is moderately fragmented. The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading addictions therapeutics manufacturers, that include Alkermes Plc, Amneal Pharmaceuticals Inc., Indivior Plc, Johnson & Johnson Services Inc., Mylan NV, Novartis AG, Novo Nordisk AS, Novo Nordisk AS, Pfizer Inc., and Teva Pharmaceutical Industries Ltd.

Also, the addictions therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Alkermes Plc
  • Indivior Plc
  • Mylan NV
  • Novartis AG
  • Novo Nordisk AS
  • Pfizer Inc.
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT
2.1 Preface
2.2 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 06: MARKET SEGMENTATION BY TYPE
  • Market segmentation by type
  • Comparison by type
  • Alcohol addiction therapeutics - Market size and forecast 2018-2023
  • Tobacco addiction therapeutics - Market size and forecast 2018-2023
  • Drug addiction therapeutics - Market size and forecast 2018-2023
  • Market opportunity by type
PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity
PART 09: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 10: MARKET TRENDS
  • Increasing R&D of novel drugs
  • Emergence of free state-run addiction treatment programs and facilities
  • Consolidation of rehabilitation centers
PART 11: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
PART 12: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Alkermes Plc
  • Amneal Pharmaceuticals Inc.
  • Indivior Plc
  • Johnson & Johnson Services Inc.
  • Mylan NV
  • Novartis AG
  • Novo Nordisk AS
  • Opiant Pharmaceuticals Inc.
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
PART 13: APPENDIX
  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors
List of Exhibits
Exhibit 01: Product overview
Exhibit 02: Global pharmaceuticals market
Exhibit 03: Segments of global pharmaceuticals market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2018
Exhibit 18: Type - Market share 2018-2023 (%)
Exhibit 19: Comparison by type
Exhibit 20: Alcohol addiction therapeutics - Market size and forecast 2018-2023 ($ millions)
Exhibit 21: Alcohol addiction therapeutics - Year-over-year growth 2019-2023 (%)
Exhibit 22: Tobacco addiction therapeutics - Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Tobacco addiction therapeutics - Year-over-year growth 2019-2023 (%)
Exhibit 24: Drug addiction therapeutics - Market size and forecast 2018-2023 ($ millions)
Exhibit 25: Drug addiction therapeutics - Year-over-year growth 2019-2023 (%)
Exhibit 26: Market opportunity by type
Exhibit 27: Customer landscape
Exhibit 28: Market share by geography 2018-2023 (%)
Exhibit 29: Geographic comparison
Exhibit 30: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 31: North America - Year-over-year growth 2019-2023 (%)
Exhibit 32: Top 3 countries in North America
Exhibit 33: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 34: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 35: Top 3 countries in Europe
Exhibit 36: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 37: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 38: Top 3 countries in Asia
Exhibit 39: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 40: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 41: Top 3 countries in ROW
Exhibit 42: Key leading countries
Exhibit 43: Market opportunity
Exhibit 44: Impact of drivers and challenges
Exhibit 45: Vendor landscape
Exhibit 46: Landscape disruption
Exhibit 47: Vendors covered
Exhibit 48: Vendor classification
Exhibit 49: Market positioning of vendors
Exhibit 50: Alkermes Plc - Vendor overview
Exhibit 51: Alkermes Plc - Business segments
Exhibit 52: Alkermes Plc - Organizational developments
Exhibit 53: Alkermes Plc - Geographic focus
Exhibit 54: Alkermes Plc - Key offerings
Exhibit 55: Alkermes Plc - Key customers
Exhibit 56: Amneal Pharmaceuticals Inc. - Vendor overview
Exhibit 57: Amneal Pharmaceuticals Inc. - Business segments
Exhibit 58: Amneal Pharmaceuticals Inc. - Organizational developments
Exhibit 59: Amneal Pharmaceuticals Inc. - Segment focus
Exhibit 60: Amneal Pharmaceuticals Inc. - Key offerings
Exhibit 61: Amneal Pharmaceuticals Inc. - Key customers
Exhibit 62: Indivior Plc - Vendor overview
Exhibit 63: Indivior Plc - Business segments
Exhibit 64: Indivior Plc - Organizational developments
Exhibit 65: Indivior Plc - Geographic focus
Exhibit 66: Indivior Plc - Key offerings
Exhibit 67: Indivior Plc - Key customers
Exhibit 68: Johnson & Johnson Services, Inc. - Vendor overview
Exhibit 69: Johnson & Johnson Services, Inc. - Business segments
Exhibit 70: Johnson & Johnson Services, Inc. - Organizational developments
Exhibit 71: Johnson & Johnson Services, Inc. - Geographic focus
Exhibit 72: Johnson & Johnson Services, Inc. - Segment focus
Exhibit 73: Johnson & Johnson Services, Inc. - Key offerings
Exhibit 74: Johnson & Johnson Services, Inc. - Key customers
Exhibit 75: Mylan NV - Vendor overview
Exhibit 76: Mylan NV - Product segments
Exhibit 77: Mylan NV - Organizational developments
Exhibit 78: Mylan NV - Geographic focus
Exhibit 79: Mylan NV - Segment focus
Exhibit 80: Mylan NV - Key offerings
Exhibit 81: Mylan NV - Key customers
Exhibit 82: Novartis AG - Vendor overview
Exhibit 83: Novartis AG - Business segments
Exhibit 84: Novartis AG - Organizational developments
Exhibit 85: Novartis AG - Geographic focus
Exhibit 86: Novartis AG - Segment focus
Exhibit 87: Novartis AG - Key offerings
Exhibit 88: Novartis AG - Key customers
Exhibit 89: Novo Nordisk AS - Vendor overview
Exhibit 90: Novo Nordisk AS - Business segments
Exhibit 91: Novo Nordisk AS - Organizational developments
Exhibit 92: Novo Nordisk AS - Geographic focus
Exhibit 93: Novo Nordisk AS - Segment focus
Exhibit 94: Novo Nordisk AS - Key offerings
Exhibit 95: Novo Nordisk AS - Key customers
Exhibit 96: Opiant Pharmaceuticals Inc. - Vendor overview
Exhibit 97: Opiant Pharmaceuticals Inc. - Business segments
Exhibit 98: Opiant Pharmaceuticals Inc. - Organizational developments
Exhibit 99: Opiant Pharmaceuticals Inc. - Key offerings
Exhibit 100: Opiant Pharmaceuticals Inc. - Key customers
Exhibit 101: Pfizer Inc. - Vendor overview
Exhibit 102: Pfizer Inc. - Business segments
Exhibit 103: Pfizer Inc. - Organizational developments
Exhibit 104: Pfizer Inc. - Geographic focus
Exhibit 105: Pfizer Inc. - Segment focus
Exhibit 106: Pfizer Inc. - Key offerings
Exhibit 107: Pfizer Inc. - Key customers
Exhibit 108: Teva Pharmaceutical Industries Ltd. - Vendor overview
Exhibit 109: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 110: Teva Pharmaceutical Industries Ltd. - Organizational developments
Exhibit 111: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibit 112: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 113: Teva Pharmaceutical Industries Ltd. - Key customers
Exhibit 114: Validation techniques employed for market sizing
Exhibit 115: Definition of market positioning of vendors
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Alkermes Plc
  • Amneal Pharmaceuticals Inc.
  • Indivior Plc
  • Johnson & Johnson Services Inc.
  • Mylan NV
  • Novartis AG
  • Novo Nordisk AS
  • Opiant Pharmaceuticals Inc.
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
Note: Product cover images may vary from those shown
Adroll
adroll